Portable Mixed Reality-based Platform for Assessment of Progress in Multisensory Rehabilitation Strategies Post-TBI
Launched by BLUEHALO · Mar 14, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study considers Praxis: a portable testbed with low-cost wearable sensors and a mixed reality environment to deliver effective multisensory rehabilitation exercises with military face-validity. Through a small comparative pilot study, the investigators plan to provide evidence for future multi-center randomized trials (MCRTs) to show that progress in these multisensory exercises correlates with established military readiness assessments; and that the improvements in functional performance in response to multisensory rehabilitation strategies is associated with changes in brain activity...
Gender
ALL
Eligibility criteria
- Inclusion Criteria for Praxis Group:
- • Participating in the SPaR Program
- • 18-50 years old
- • Have a self-reported or clinician-confirmed mTBI
- • Have continued complaints of dizziness/imbalance
- • Are right-handed as determined by the Edinburgh Handedness Inventory-Short Form
- Inclusion Criteria for Control Group:
- • Participating in the SPaR Program
- • 18-50 years old
- • No complaints of dizziness/imbalance
- Exclusion Criteria:
- • Having impaired mental capacity (e.g., altered capacity due to administration of any mind-altering substances or stress/life situations)
- • Displaying behavior that would significantly interfere with validity of data collection or safety during the study
- • Reporting significant pain during the evaluation (7/10 by patient subjective report)
- • Being pregnant (balance considerations)
- • Being unable to abstain from the use of alcohol and medications that might impair participant's balance or cerebral blood flow for 24 hours in advance of testing
- • Being mixed or left-handed as determined by the Edinburgh Handedness Inventory-Short Form for the Praxis group undergoing rs-fMRI.
About Bluehalo
BlueHalo is a forward-thinking clinical trial sponsor dedicated to advancing innovative therapeutics through rigorous research and development. With a focus on enhancing patient outcomes, BlueHalo collaborates with healthcare professionals and research institutions to design and execute clinical trials that adhere to the highest standards of scientific integrity and ethical practice. Leveraging cutting-edge technologies and a patient-centric approach, BlueHalo aims to accelerate the discovery of novel treatments while ensuring safety and efficacy throughout the clinical trial process.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Fort Sam Houston, Texas, United States
Patients applied
Trial Officials
Pedram Hovareshti, PhD
Principal Investigator
BlueHalo
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported